Skip to main content
BIO-TECHNE Corp logo

BIO-TECHNE Corp — Investor Relations & Filings

Ticker · TECH ISIN · US09073M1045 LEI · 54930073RLKQ51TILZ35 US Manufacturing
Open in API
Filings indexed 1,013 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US TECH

About BIO-TECHNE Corp

https://www.bio-techne.com/

Bio-Techne Corporation is a global developer, manufacturer, and supplier of high-quality reagents, analytical instruments, and services for the research and clinical diagnostic markets. The company's portfolio includes a wide range of life science tools such as recombinant proteins, antibodies, and immunoassays offered through its family of brands. Bio-Techne also provides automated platforms for protein characterization, including Simple Western and iCE systems, alongside next-generation Simple Plex assays. The company supports scientific discovery and accelerates the development of cell and gene therapies by delivering solutions focused on reproducibility and consistency, complemented by custom manufacturing and testing services.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 82% confidence The document is clearly an SEC Form SD (“Specialized Disclosure Report”) filed under Rule 13p-1 for conflict minerals. It is a regulatory disclosure/report rather than an annual or quarterly financial report, governance proxy, or other specific category. It does not contain substantive financial statements or presentation materials, but is a required SEC filing providing compliance information. Therefore, it falls under general regulatory filings.
2026-06-01 English
10-Q - BIO-TECHNE Corp (0000842023) (Filer)
Interim / Quarterly Report
2026-05-06 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-06 English
8-K - BIO-TECHNE Corp (0000842023) (Filer)
Regulatory Filings Classification · 90% confidence The document is a SEC Form 8-K current report, containing Item 2.02 (results of operations press release) and Item 8.01 (cash dividend press release), but does not itself include the full financial statements or standalone report. It is an event-driven regulatory filing under the Exchange Act, not a full earnings release or standalone dividend notice. There is no specific 8-K category, so it falls into the general Regulatory Filings (RNS) bucket.
2026-05-06 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-29 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-03-26 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.